*Treatment of intermediate-2 and high-risk myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia, in adults who are not eligible for haemotopoietic stem cell transplantation:* BY SC INJ: Adult: 75 mg/m2 IV or SC injection once a day for 7 days; repeat cycle every 4...
| Brand Name | Manufacturer / Company | Available Pack Sizes & Price | Action |
|---|---|---|---|
| AZALID AQVIDA | 🏢 HIMMEL |
Inj 100mg 1 Vial:
N/A
|
View Details → |
Other generic formulations in the same therapeutic groups as AZACITIDINE.